http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2238096-C1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
filingDate 2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08cdb13e665ed26d6db7771c1a8b6948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3244f80c3dfe8c940ceae5ee93fd917e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23b35535db2aba84dce387a12f71a51b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea5f7247ba2168525d0568acb7bdc9aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf8ba35d8a46ccdc9b922cceb8007a8
publicationDate 2004-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2238096-C1
titleOfInvention Method for treating autoimmune sterility in men
abstract FIELD: medicine, urology, andrology. n SUBSTANCE: one should introduce prednisolone at daily dosage being 1.2 mg/kg patient's body weight for 5 d. Then comes plasmapheresis course to normalize the quantity of antispermal antibodies (AA) in patient's blood. Application of the present method enables to improve both quantitative and qualitative values of spermatogenesis due to removing AA out of ejaculate and, also, prevent complications of glucocorticoid therapy. n EFFECT: higher efficiency of therapy. n 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2510284-C1
priorityDate 2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506586

Total number of triples: 19.